Literature DB >> 25265426

Specific MicroRNAs Differentiate Adrenocortical Adenomas from Carcinomas and Correlate With Weiss Histopathologic System.

Meora Feinmesser1, Carlos Benbassat, Eti Meiri, Hila Benjamin, Danit Lebanony, Yael Lebenthal, Liat de Vries, Tamara Drozd, Yael Spector.   

Abstract

MicroRNAs (miRs) play a central role in regulating gene expression and are strongly associated with cancer development. This study sought to determine if adrenocortical carcinomas can be differentiated from adenomas by their miR profiles and to correlate the findings with the histologic Weiss system for identifying malignancy in adrenocortical tumors (ACTs). Forty-six primary and 2 recurrent ACTs retrieved from the files of the pathology department of a tertiary medical center were evaluated blindly for the Weiss criteria. High-quality RNA was extracted, and miR expression was evaluated with microarrays and quantitative reverse-transcriptase polymerase chain reaction. The Weiss system defined 17 tumors as carcinomas and 29 as adenomas. On microarray analysis, over a dozen miRs were upregulated or downregulated in carcinomas compared with adenomas. Upregulation of miR-503 was the best single discriminator of malignancy. The combination of miR-34a and miR-497 underexpression discriminated carcinomas from adenomas with 100% sensitivity and 96% specificity. Statistical analysis revealed a high level of correspondence between the Weiss system and miR expression. In conclusion, miR expression can accurately identify malignant ACTs with equal efficiency to the Weiss system. miR analysis may have added value in tumors with borderline features that are difficult to interpret histopathologically.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25265426     DOI: 10.1097/PAI.0000000000000117

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  12 in total

Review 1.  The role of microRNAs in the adrenocortical carcinomas.

Authors:  Xin Yu; Zheng Li
Journal:  Tumour Biol       Date:  2015-12-15

2.  MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines.

Authors:  Su-Chen Li; Azita Monazzam; Masoud Razmara; Xia Chu; Peter Stålberg; Britt Skogseid
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

3.  TGF-â1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.

Authors:  Pin Guo; Yanan Yu; Huanting Li; Daoxiang Zhang; Anjing Gong; Shifang Li; Wei Liu; Lei Cheng; Yongming Qiu; Weicheng Yao; Luo Li; Yugong Feng
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

4.  Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy.

Authors:  Łukasz Koperski; Marta Kotlarek; Michał Świerniak; Monika Kolanowska; Anna Kubiak; Barbara Górnicka; Krystian Jażdżewski; Anna Wójcicka
Journal:  Oncotarget       Date:  2017-07-25

Review 5.  Translational applications of microRNAs in cancer, and therapeutic implications.

Authors:  Grace T Kwok; Jing Ting Zhao; Jocelyn Weiss; Nancy Mugridge; Himanshu Brahmbhatt; Jennifer A MacDiarmid; Bruce G Robinson; Stan B Sidhu
Journal:  Noncoding RNA Res       Date:  2017-12-20

6.  Multi-dimensional data integration algorithm based on random walk with restart.

Authors:  Yuqi Wen; Xinyu Song; Song He; Xiaochen Bo; Bowei Yan; Xiaoxi Yang; Lianlian Wu; Dongjin Leng
Journal:  BMC Bioinformatics       Date:  2021-02-27       Impact factor: 3.169

7.  Tissue miRNA Combinations for the Differential Diagnosis of Adrenocortical Carcinoma and Adenoma Established by Artificial Intelligence.

Authors:  Péter István Turai; Zoltán Herold; Gábor Nyirő; Katalin Borka; Tamás Micsik; Judit Tőke; Nikolette Szücs; Miklós Tóth; Attila Patócs; Peter Igaz
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

Review 8.  Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers.

Authors:  Yuling Cheng; Wei Kou; Dandan Zhu; Xinbo Yu; Yu Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-01       Impact factor: 5.555

Review 9.  microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges.

Authors:  Nadia Cherradi
Journal:  Front Endocrinol (Lausanne)       Date:  2016-01-20       Impact factor: 5.555

Review 10.  miR-497 expression, function and clinical application in cancer.

Authors:  Gang Yang; Guangbing Xiong; Zhe Cao; Suli Zheng; Lei You; Taiping Zhang; Yupei Zhao
Journal:  Oncotarget       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.